Heavyweight new drug approved. Merck's stock price reaches a new historical high, from Wall Street to Lujiazui
阿豆学长长ov
发表于 2024-3-29 12:07:57
251
0
0
The heavyweight new drug has been approved, and Merck's stock price has reached a new historical high. Winrevair expects annual sales of $5 billion for patients with pulmonary arterial hypertension (PAH).
CandyLake.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
转播
猜你喜欢
- Has the release of heavyweight data in the United States stabilized interest rate cuts? What do you think of Wall Street?
- Global highlights for next week: Super central bank hits hard, Federal Reserve's favorite inflation indicator released
- One week outlook | Led by the Federal Reserve, the last "central bank super week" of the year is coming with a heavy blow; China's November economic data and important inflation data from the United States are about to be released
- Wall Street is guessing that the Federal Reserve won't be able to lower interest rates many times next year? There are still traders who don't buy it!
- Heavy night! The Federal Reserve cuts interest rates by 25 basis points, causing the US dollar to soar instantly! The latest interpretation has arrived
- Worries may become a reality! Wall Street frenzy hit hard, can the US stock market continue its strong performance next year
- Will there only be two interest rate cuts next year? Wall Street: The Federal Reserve may change its mind, and the current sell-off is a good opportunity to buy at the bottom!
- Major changes in the Federal Reserve! The prospect of interest rate cuts changes, leading to heated discussions on Wall Street
- Will the Federal Reserve return to the path of raising interest rates next year? Top Wall Street Economist: 40% Probability
- Global highlights next week: Wall Street cautious over Chinese New Year, key to Trump's long short relationship with Federal Reserve
